New

Global ETF Survey 2026: Answer now →

Help us improve your experience. Please confirm your investor type:

Compare ETFs Easily

The Ultimate ETF Comparison Tool - Try Now!

Analyze up to 5 ETFs side-by-side and gain instant insights on performance, fees, holdings, and more to make data-driven investment decisions.

›ETF Issuers›iShares›IYH
IYH

iShares U.S. Healthcare ETF

The IYH Exchange Traded Fund (ETF) is provided by iShares. It is built to track an index: Russell 1000 Health Care RIC 22.5/45 Capped Gross Index. The IYH ETF provides physical exposure, so by buying it you actually own parts of all the 103 underlying holdings. This share class generates a stream of income by distributing dividends.

Advertisement

Advertisement

$66.88
-$1.1 (-1.65%) today
5:30 PM 07/14/26 Open
1D price range
$66.52$67.30
52W price range
$54.35$69.55
YTD Perf.
+5.01%
YTD Flows
Annualized volatility
Fund AuM
€2.82B
Share class AuM
€2.82B
TTM Yield
Tracking Error
Tracking Difference
ISIN
US4642877629
TER
0.38%
Inception date
6/12/2000
Issuer
Replication method
Dividend policy
Compare similar ETFs
API
PerformanceDec 31, 2025 - Jul 13, 2026
-5%0%5%JANMARMAYJUL
Flows
Join for free to unlock
Data as of 05/31/26
Healthcare
99.83%
Unavailable
0.10%
Latest IYH news

No content available for this fund

FAQ about IYH

IYH is a Passive ETF. This ETF provides exposure to Large and Mid-Cap US Health Care Equities.
IYH tracks the Russell 1000 Health Care RIC 22.5/45 Capped Gross Index - USD, through a full replication replication method.
IYH carries a total expense ratio (TER) of 0.38%, indicating the annual cost for holding the fund.
IYH was introduced to the market on June 12, 2000. It trades on United States
iShares U.S. Healthcare ETF, IYH, is provided by iShares. Learn more about iShares here.
IYH oversees €2.82B in assets as of July 13, 2026.
IYH follows a distributing dividend policy, meaning it pays out income to investors. As of July 13, 2026, its 12-month trailing yield was 1.18%.
As of May 31, 2026, IYH has significant geographic allocations in USA and Ireland.
As of May 31, 2026, IYH focuses largely on Healthcare.
As of May 31, 2026, IYH holds 103 positions in its portfolio, with 69.40% of assets concentrated in its top 15 holdings.
As of May 31, 2026, IYH top three holdings include Eli Lilly & Co., Johnson & Johnson and AbbVie, Inc..
The base currency of IYH is USD.
Data as of 05/31/26
Eli Lilly & Co.
15.81%
Johnson & Johnson
9.68%
AbbVie, Inc.
6.89%
UnitedHealth Group, Inc.
6.18%
Merck & Co., Inc.
5.27%
Thermo Fisher Scientific, Inc.
3.32%
Amgen, Inc.
3.24%
Gilead Sciences, Inc.
2.99%
Intuitive Surgical, Inc.
2.68%
Pfizer Inc.
2.66%

Trackinsight
Essentials

A forever free toolbox for fund selection, analysis, research, and ETF portfolio construction.

Essential free account includes:
  • More fund data
  • Compare up to 3 funds
  • More screener filters
  • Edit screener columns from 100+ metrics
  • Watchlists for saving your research
  • Portfolio construction and analysis
  • Personal dashboard for live monitoring

Advertisement

Trackinsight

About Trackinsight

Since our founding in 2016, we have been at the forefront of the industry, delivering accessible, comprehensive, and reliable tools to support the evolving needs of investors.

Over the past decade, Trackinsight has expanded its operations across six countries, serving thousands of professional investors. We’ve consistently innovated to provide cutting-edge solutions that meet the changing demands of the ETF market.

In 2024, Kepler Cheuvreux, a leading independent European financial services firm, acquired a majority stake in Trackinsight, becoming the company's principal shareholder.

This strategic partnership solidifies Trackinsight's position as a premier provider of ETF selection and analysis tools, while strengthening Kepler Cheuvreux’s commitment to becoming a leading player in the ETF sector.

Together, we are committed to offering advanced services that empower professional investors, advisors, institutions, and issuers. This new step enables us to deliver even more comprehensive and innovative technological solutions, driving ETF investing to new heights.

More about Trackinsight
© 2014-2026 Trackinsight SA. All rights reserved.
Privacy policy  |  Cookie policy  |    |  Terms of use  |  Imprint
Trackinsight